Xuan Lei

Ms. Xuan Lei

Dermatology, Heidelberg University, Heidelberg, Baden-Württemberg, Germany
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
XLXuan Lei
Xuan Lei
SRSabine Ring
Sabine Ring
SJShiying Jin
Shiying Jin
SSSonali Singh
Sonali Singh
KMKarsten Mahnke
Karsten Mahnke
Extracellular vesicles (EVs), including exosomes, microvesicles, and apoptotic bodies, are released into the extracellular space by almost all known cell types. They facilitate communication between cells by transferring bioactive molecules, which impact both physiological processes and the development of diseases. EVs play a crucial role in the pathogenesis of various diseases by participating in multiple pathological processes. They contribute to disease progression by triggering cytokine release, modulating immune cell activity, and inducing inflammatory and immune responses. Beyond their pathological implications, EVs also offer significant therapeutic potential. Both natural and engineered EVs show great potential in the fields of targeted therapy, drug delivery, and immune modulation in dermatological applications. The development of EV-based treatments is showing promise in advancing patient outcomes, particularly in chronic inflammatory and immune-mediated skin conditions. This review comprehensively examined the biogenesis, classification, and functional roles of EVs, including advanced methods for their isolation and characterization. Furthermore, we summarized recent studies highlighting the involvement of EVs in four major inflammatory skin diseases: psoriasis, atopic dermatitis, systemic lupus erythematosus, and wound healing.

Verified
Journal Article
Open access
PDF file
LCLuxia Chen
Luxia Chen
XLXuan Lei
Xuan Lei
KMKarsten Mahnke
Karsten Mahnke
Inflammatory skin diseases highlight inflammation as a central driver of skin pathologies, involving a multiplicity of mediators and cell types, including immune and non-immune cells. Adenosine, a ubiquitous endogenous immune modulator, generated from adenosine triphosphate (ATP), acts via four G protein-coupled receptors (A1, A2A, A2B, and A3). Given the widespread expression of those receptors and their regulatory effects on multiple immune signaling pathways, targeting adenosine receptors emerges as a compelling strategy for anti-inflammatory intervention. Animal models of psoriasis, contact hypersensitivity (CHS), and other dermatitis have elucidated the involvement of adenosine receptors in the pathogenesis of these conditions. Targeting adenosine receptors is effective in attenuating inflammation and remodeling the epidermal structure, potentially showing synergistic effects with fewer adverse effects when combined with conventional therapies. What is noteworthy are the promising outcomes observed with A2A agonists in animal models and ongoing clinical trials investigating A3 agonists, underscoring a potential therapeutic approach for the management of inflammatory skin disorders.

4 June 2025 in Immunology
Verified
Journal Article
Open access
SJShiying Jin
Shiying Jin
XLXuan Lei
Xuan Lei
SSSonali Singh
Sonali Singh
AEAlexander Enk
Alexander Enk
KMKarsten Mahnke
Karsten Mahnke
The surface molecule DEC205 (CD205) is well‐characterised in murine dendritic cells (DCs) as an antigen uptake receptor. However, recent studies have also identified its expression in other leukocytes, including B cells and neutrophils. In B cells, DEC205 functions as an endocytic receptor, similar to its role in DCs. Since neutrophils are not professional antigen‐presenting cells, we sought to investigate the functions of DEC205 beyond endocytosis. Analysis of cell surface expression of DEC205 in neutrophils at different maturation stages and anatomical locations revealed its downregulation upon in vitro activation and during tissue infiltration, such as in skin inflammation and thioglycolate‐induced peritonitis. In DEC205‐deficient (DEC205−/−) mice, neutrophils exhibited reduced migration in Boyden chamber assays and impaired accumulation in the peritoneum, along with decreased adhesion to extracellular matrix proteins. These findings suggest that, beyond its established role as an antigen uptake receptor in antigen‐presenting cells, DEC205 may serve as a marker for early‐stage neutrophils with the capacity to migrate and infiltrate tissues.

12 May 2026 in Cells
Verified
Journal Article
Open access
PDF file
SSSonali Singh
Sonali Singh
SRSabine Ring
Sabine Ring
XLXuan Lei
Xuan Lei
MAMohamad Alabdullah
Mohamad Alabdullah
YIYutaka Inaba
Yutaka Inaba
KMKarsten Mahnke
Karsten Mahnke
The surface receptor DEC205 (alias CD205, NLDC-145, Ly75) has long been a marker for murine dendritic cells and Langerhans cells and functions as receptor to facilitate antigen uptake. We revisited the tissue expression pattern of DEC205 in mice and revealed expression by endothelial cells (ECs) in the central nervous system. Using the murine brain-derived EC line bEnd.3, we could show that DEC205 serves as an endocytic receptor that directs potential ligands to lysosomal compartments. As for its function in ECs, upon engagement by anti-DEC205 antibodies, DEC205 seems to guide Claudin 5, a component of endothelial junctions, away from the surface of ECs to a LAMP-1+, degradative compartment. This opens endothelial junctions, eventually allowing leukocytes to migrate from blood to tissue sites. In aggregate, by regulating the blood–brain barrier, DEC205 in ECs may contribute to the regulation of inflammatory processes in the central nervous system.